HDAC1 and Familial prostate cancer: Weichert and colleagues demonstrated that HDAC1, HDAC2, and HDAC3 are overexpressed in prostate cancers, whereas increased expression of HDAC1 and HDAC2 correlates with higher Gleason scores.